Raltegravir is an antiretroviral drug used to treat HIV infections. It works by inhibiting integrase, an enzyme the virus needs to integrate its genetic material into the host's DNA. Raltegravir is part of combination therapy and helps reduce the viral load and prevent the progression of HIV to AIDS.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Raltegravir and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Raltegravir impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Raltegravir-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.